FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

900000000000490003: Description inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001069012 Description inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001070013 Description inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001071012 Description inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


504101 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Description inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
salbutamol 0,083 %, lösning Nonconformance to editorial policy component (foundation metadata concept)
salbutamol 0,5 %, lösning Nonconformance to editorial policy component (foundation metadata concept)
salbutamol 100 mikrogram + ipratropiumbromid 20 mikrogram, inhalator Concept non-current
salbutamol 100 mikrogram, CFC-fri andningsaktiverad aerosolinhalator Concept non-current
salbutamol 100 mikrogram, CFC-fri inhalator Concept non-current
salbutamol 100 mikrogram, andningsaktiverad aerosolinhalator Concept non-current
salbutamol 100 mikrogram, inhalator Concept non-current
salbutamol 2 mg, tablett Nonconformance to editorial policy component (foundation metadata concept)
salbutamol 2 mg/5 ml, sockerfri sirap Concept non-current
salbutamol 2,5 mg + ipratropiumbromid 500 mikrogram, för nebulisator Concept non-current
salbutamol 2,5 mg/2,5 ml, för nebulisator Concept non-current
salbutamol 200 mikrogram, andningsaktiverad pulverinhalator Concept non-current
salbutamol 200 mikrogram, blisterskivor för påfyllning Concept non-current
salbutamol 200 mikrogram, inhalationskapsel Concept non-current
salbutamol 200 mikrogram, kapsel Concept non-current
salbutamol 200 mikrogram/blisterskivor + diskhaler Concept non-current
salbutamol 200 mikrogram/dos, pulver för inhalation Nonconformance to editorial policy component (foundation metadata concept)
salbutamol 250 mikrogram/5 ml, injektion Concept non-current
salbutamol 4 mg, kapsel med modifierad frisättning Concept non-current
salbutamol 4 mg, tablett Concept non-current
salbutamol 40 mg, tablett med modifierad frisättning Concept non-current
salbutamol 400 mikrogram, blisterskivor + diskhaler Concept non-current
salbutamol 400 mikrogram, blisterskivor för påfyllning Concept non-current
salbutamol 400 mikrogram, inhalationskapsel Concept non-current
salbutamol 5 mg/2,5 ml, för nebulisator Concept non-current
salbutamol 5 mg/50 ml, injektion Concept non-current
salbutamol 50 mg/5 ml, intravenös infusion Concept non-current
salbutamol 500 mikrogram/ml, injektion Concept non-current
salbutamol 8 mg, kapsel med modifierad frisättning Concept non-current
salbutamol 8 mg, tablett med modifierad frisättning Concept non-current
salbutamol 90 mikrogram per inhalation, aerosol Concept non-current
salbutamol 95 mikrogram, andningsaktiverad pulverinhalator Concept non-current
salbutamol för oralt bruk Nonconformance to editorial policy component (foundation metadata concept)
salbutamol för pulmonellt bruk Nonconformance to editorial policy component (foundation metadata concept)
salbutamolförgiftning, med oklar avsikt Concept non-current
salbutamolpreparat för inhalation Concept non-current
salbutamolpreparat för parenteralt bruk Nonconformance to editorial policy component (foundation metadata concept)
salbutamolsulfat 0,63 mg/3 ml, lösning Nonconformance to editorial policy component (foundation metadata concept)
salbutamolsulfat 1,25 mg/3 ml, lösning Nonconformance to editorial policy component (foundation metadata concept)
salbutamolsulfat 100 mg/20 ml, lösning för nebulisator Concept non-current
salbutamolsulfat 103 mikrogram + ipratropiumbromid 18 mikrogram, aerosol Concept non-current
salbutamolsulfat 3 mg + ipratropiumbromid 0,5 mg, lösning för inhalation Nonconformance to editorial policy component (foundation metadata concept)
salbutamolsulfat 8 mg, tablett Nonconformance to editorial policy component (foundation metadata concept)
salicylaldehyd Nonconformance to editorial policy component (foundation metadata concept)
salicylamid Nonconformance to editorial policy component (foundation metadata concept)
salicylat för lokalt bruk Concept non-current
salicylatextrakt Concept non-current
salicylatprodukt Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra + koltjära + svavel Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra + svavel Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra + zinkoxid Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 1 % + antrakinonglykosider 0,5 %, för pensling i munnen Concept non-current
salicylsyra 11 %, gel Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 12 % / mjölksyra 4 %, gel Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 16,7 % + mjölksyra 16,7 %, preparat för pensling Concept non-current
salicylsyra 17 %, vätska Concept non-current
salicylsyra 2 %, lösning Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 2 %, lösning för lokalt bruk Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 25 % + mjölksyra 25 %, salva Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 26 %, lösning för lokalt bruk Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 3 % + borsyra 5 %, puder Concept non-current
salicylsyra 3 % + borsyra i renat talk 5 %, pulver Concept non-current
salicylsyra 3 % + svavel 5 %, schampo Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 5 % + zinkoxid 20 %, puder Concept non-current
salicylsyra 5 % + zinkoxid 20 %, puder Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 50 %, salva Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 6 %, gel Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra 60 % i vitt mjukt paraffin 40 %, salva Concept non-current
salicylsyra 600 mg/g + vitt vaselin 400 mg/g, kutan salva Nonconformance to editorial policy component (foundation metadata concept)
salicylsyra för lokalt bruk Concept non-current
salicylsyra och dess derivat Nonconformance to editorial policy component (foundation metadata concept)
salicylsyragel Concept non-current
salicylsyraplåster 20 %, 7,5 cm x 4,5 cm Concept non-current
salicylsyraplåster 40 %, 7,5 cm x 4,5 cm Concept non-current
salinomycin Nonconformance to editorial policy component (foundation metadata concept)
salivstimulerande medel Concept non-current
salivstimulerande tablett Concept non-current
salixpollenallergen Concept non-current
sallat, livsmedel Concept non-current
salmeterol Nonconformance to editorial policy component (foundation metadata concept)
salmeterol (som salmeterolxinafoat) 25 mikrogram/dos, trycksatt suspension för inhalation Nonconformance to editorial policy component (foundation metadata concept)
salmeterol (som salmeterolxinafoat) 50 mikrogram/dos, pulver för inhalation Nonconformance to editorial policy component (foundation metadata concept)
salmeterol 25 mikrogram + flutikasonpropionat 125 mikrogram, CFC-fri inhalator Concept non-current
salmeterol 25 mikrogram + flutikasonpropionat 125 mikrogram, inhalator Concept non-current
salmeterol 25 mikrogram + flutikasonpropionat 250 mikrogram, CFC-fri inhalator Concept non-current
salmeterol 25 mikrogram + flutikasonpropionat 250 mikrogram, inhalator Concept non-current
salmeterol 25 mikrogram + flutikasonpropionat 50 mikrogram, CFC-fri inhalator Concept non-current
salmeterol 25 mikrogram + flutikasonpropionat 50 mikrogram, inhalator Concept non-current
salmeterol 25 mikrogram, inhalator Concept non-current
salmeterol 50 mikrogram + flutikasonpropionat 100 mikrogram, andningsaktiverad pulverinhalator Concept non-current
salmeterol 50 mikrogram + flutikasonpropionat 250 mikrogram, andningsaktiverad pulverinhalator Concept non-current
salmeterol 50 mikrogram + flutikasonpropionat 500 mikrogram, andningsaktiverad pulverinhalator Concept non-current
salmeterol 50 mikrogram, andningsaktiverad pulverinhalator Concept non-current
salmeterol 50 mikrogram, blisterskivor + diskhaler Concept non-current
salmeterol 50 mikrogram, blisterskivor för påfyllning Concept non-current
salmeterolxinafoat 21 mikrogram/sprejdos, aerosol Concept non-current
salmeterolxinafoat 38,06 mikrogram, inhalationsmedel Concept non-current
salmeterolxinafoat 50 mikrogram, pulver Concept non-current
salmon specific IgE Nonconformance to editorial policy component (foundation metadata concept)
salmonellaart Concept non-current

Start Previous Page 4934 of 5042 Next End


Reference Sets

Reference set descriptor

Description inactivation indicator reference set

GB English

US English

Back to Start